Fairpoint Group PLC
07 January 2008
Form TR-1 with annex. FSA Version 2.1 updated April 2007
For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: Notifications of Major Interests in Shares
Fairpoint Group plc (was Debt Free
Direct plc)
1. Identity of the issuer or the underlying issuer of
existing shares to which voting rights are attached:
2. Reason for notification (yes/no)
Yes
An acquisition or disposal of voting rights
No
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
No
An event changing the breakdown of voting rights
No
Other (please specify):_Share issue by company_____________
Matthew R Peacock
3. Full name of person(s) subject to notification
obligation:
Hanover General Partner I Limited
Hanover I Fund where the shares are registered
in the name of Vidacos Nominees Limited
Hanover I Master Fund LP where the shares are
registered in the name of Vidacos Nominees
Limited
As above
4. Full name of shareholder(s) (if different from
3):
04 January 2008
5. Date of transaction (and date on which the
threshold is crossed or reached if different):
04 January 2008
6. Date on which issuer notified:
19%
7. Threshold(s) that is/are crossed or reached:
8: Notified Details
A: Voting rights attached to shares
Class/type of Situation previous to the Resulting situation after the triggering transaction
shares triggering transaction
Number of Number of Number of Number of voting rights Percentage of voting
If possible shares voting shares rights
use ISIN code rights
Direct Indirect Direct Indirect
GB0032360280 7,797,975 7,797,975 8,062,975 8,062,975 19.01%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting
instrument period/date that may be acquired rights
(if the instrument
exercised/converted)
Total (A+B)
Number of voting rights Percentage of voting rights
8,062,975 19.01%
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
Vidacos Nominees Limited controls the total voting rights; being the vehicle managed by the Prime Broker to Hanover I
Fund LP and Hanover I Fund.
Proxy Voting:
10. Name of proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
14 Contact name: Steven Prowse
15. Contact telephone name: 0207 766 8400
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.